IBD metabonomics predicts phenotype, disease course, and treatment response

Metabonomics in inflammatory bowel disease (IBD) characterizes the effector molecules of biological systems and thus aims to describe the molecular phenotype, generate insight into the pathology, and predict disease course and response to treatment. Nuclear magnetic resonance (NMR) spectroscopy, mas...

Full description

Bibliographic Details
Main Authors: Jacob T. Bjerrum, Yulan L. Wang, Jakob B. Seidelin, Ole H. Nielsen
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003443